ACE inhibitor, beta blocker may thwart cardiotoxicity from chemotherapy: Pilot study

16.04.20132134
Lasting cardiac damage from chemotherapy is a tragedy: cancer patients are cured of one life-threatening disease, only to succumb to another—heart failure—as a result of the treatment.

Reports of young cardiologists of the Global Educational Forum “Russian Cardiovascular Days”

16.04.20132754
The young cardiologists having attended the Forum provided their written reports of the Event

L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis

15.04.20131830
To evaluate the effects of L-carnitine compared with placebo or control on morbidity and mortality in the setting of acute myocardial infarction.

Weight Loss after Gastric Bypass Surgery in Human Obesity Remodels Promoter Methylation

12.04.20132044
DNA methylation provides a mechanism by which environmental factors can control insulin sensitivity in obesity.

Variables associated with change in blood pressure control status after 1-year follow up in primary care: a retrospective analysis: the TAPAS study

11.04.20131845
This 1-year, retrospective, observational study assessed factors associated with changes in hypertension control status and differences in blood pressure (BP) management among general practitioners in Spain.

Outcomes Associated With MicroalbuminuriaEffect Modification by Chronic Kidney Disease

10.04.20131761
This study sought to compare the association of microalbuminuria with outcomes in patients with different comorbidities.

Atherosclerosis 2013: prevention, diagnostics and treatment Annual collaborative meeting 2013 of Italian and Russian Societies of Atherosclerosis (under the auspices of European Society of Atherosclerosis and Russian Society of Cardiology)

10.04.20132571
On March 2-3, 2013 in Rome, an annual collaborative meeting of Russian experts in diagnosis and treatment of atherosclerosis and experts of the Italian Atherosclerosis Society was held.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.